DE1935402C3 - - Google Patents

Info

Publication number
DE1935402C3
DE1935402C3 DE1935402A DE1935402A DE1935402C3 DE 1935402 C3 DE1935402 C3 DE 1935402C3 DE 1935402 A DE1935402 A DE 1935402A DE 1935402 A DE1935402 A DE 1935402A DE 1935402 C3 DE1935402 C3 DE 1935402C3
Authority
DE
Germany
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1935402A
Other versions
DE1935402A1 (de
DE1935402B2 (de
Inventor
Miguel A. Ondetti
Josip Pluscec
John T. Middlesex Sheehan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of DE1935402A1 publication Critical patent/DE1935402A1/de
Publication of DE1935402B2 publication Critical patent/DE1935402B2/de
Application granted granted Critical
Publication of DE1935402C3 publication Critical patent/DE1935402C3/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE1935402A 1968-07-18 1969-07-11 Cholecystokinin-aktive Peptide und ihre Verwendung als Diagnosehilfsmittel Granted DE1935402B2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74568868A 1968-07-18 1968-07-18

Publications (3)

Publication Number Publication Date
DE1935402A1 DE1935402A1 (de) 1970-01-22
DE1935402B2 DE1935402B2 (de) 1974-04-04
DE1935402C3 true DE1935402C3 (de) 1974-11-07

Family

ID=24997811

Family Applications (1)

Application Number Title Priority Date Filing Date
DE1935402A Granted DE1935402B2 (de) 1968-07-18 1969-07-11 Cholecystokinin-aktive Peptide und ihre Verwendung als Diagnosehilfsmittel

Country Status (8)

Country Link
US (1) US3579494A (de)
JP (1) JPS4813115B1 (de)
CA (1) CA959830A (de)
CH (1) CH513127A (de)
DE (1) DE1935402B2 (de)
FR (1) FR2013212B1 (de)
GB (1) GB1281383A (de)
HU (1) HU163786B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705140A (en) * 1967-10-05 1972-12-05 Luigi Bernardi Peptides related to the c-terminal sequence of cck-pz and caerulein
US3839315A (en) * 1968-05-03 1974-10-01 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
US3892726A (en) * 1969-05-27 1975-07-01 Squibb & Sons Inc Tyrosine-O-sulfate containing peptides
BE754248R (fr) * 1969-08-01 1971-02-01 Farmaceutici Italia Polypeptides a activite
US3723406A (en) * 1969-12-23 1973-03-27 Squibb & Sons Inc Novel peptides having cholecystokinin activity and intermediates therefor
US3875137A (en) * 1973-04-20 1975-04-01 Searle & Co N-Substituted aspactyl peptide amids
USRE29324E (en) * 1973-04-20 1977-07-26 G. D. Searle & Co. N-Substituted aspartyl peptide amides
DD128973B1 (de) * 1976-11-29 1979-11-28 Hartmut Niedrich Verfahren zur herstellung von peptiden,die tyrosinsulfat enthalten
DE3066728D1 (en) * 1979-04-30 1984-03-29 Max Planck Gesellschaft Tyrosine derivatives, process for their production and their use in the synthesis of peptides
JPS5822474B2 (ja) * 1980-06-10 1983-05-09 天野製薬株式会社 コレシストキニン・パンクレオザイミンｃ端ペプチドアミドスルフエ−トエステルの製造法
US4769445A (en) * 1985-03-04 1988-09-06 Pennwalt Corporation Process for the solid phase synthesis of peptides which contain sulfated tyrosine
GB0105069D0 (en) 2001-03-01 2001-04-18 Univ Ulster The Modified peptide

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3705140A (en) * 1967-10-05 1972-12-05 Luigi Bernardi Peptides related to the c-terminal sequence of cck-pz and caerulein

Also Published As

Publication number Publication date
US3579494A (en) 1971-05-18
CH513127A (fr) 1971-09-30
JPS4813115B1 (de) 1973-04-25
HU163786B (de) 1973-10-27
FR2013212A1 (de) 1970-03-27
GB1281383A (en) 1972-07-12
FR2013212B1 (de) 1974-05-24
DE1935402A1 (de) 1970-01-22
CA959830A (en) 1974-12-24
DE1935402B2 (de) 1974-04-04

Similar Documents

Publication Publication Date Title
AU1946070A (de)
AU428130B2 (de)
AU2374870A (de)
AU5184069A (de)
AU6168869A (de)
AU6171569A (de)
AU429879B2 (de)
AU416157B2 (de)
AU2581067A (de)
AU4811568A (de)
AU421558B1 (de)
AU3789668A (de)
AU3224368A (de)
AU2580267A (de)
AU4744468A (de)
AU479393A (de)
BE642636A (de)
AU4558658A (de)
AU463027A (de)
BE709435A (de)
BE709415A (de)
AU479894A (de)
AU4464266A (de)
AU4270368A (de)
AU4224469A (de)

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)